OpenAlex
PricingAboutJobs
Log inGet started
Work

Dapagliflozin as add‐on therapy in Asian patients with type 2 diabetes inadequately controlled on insulin with or without oral antihyperglycemic drugs: A randomized controlled trial

HTML

Year: 2018
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Journal of Diabetes
DOI: 10.1111/1753-0407.12634
Authors: Wenying Yang, Jianhua Ma, Yiming Li, Yanbing Li, Zhiguang Zhou, Jae Hyeon Kim, June Zhao, Agata Ptaszynska
Institutions: China-Japan Friendship Hospital, Jiangsu Province Hospital, Nanjing First Hospital, Nanjing Medical University, Shanghai Medical College of Fudan University, Fudan University, Huashan Hospital, Sun Yat-sen University, Second Xiangya Hospital of Central South University, Samsung Medical Center, Sungkyunkwan University, AstraZeneca (United States), Bristol-Myers Squibb (United States)
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: dapagliflozin, type 2 diabetes, adjunctive therapy, insulin, oral antidiabetic drugs, inadequate glycemic control, SGLT2 inhibitors, HbA1c, fasting blood glucose, body weight, blood pressure, hypoglycemia, adverse events, Asian patients, drug safety and efficacy
SDG: Good health and well-being

Open Access status: closed

Funder: AstraZeneca
OpenAlex ID: W2772966699
FWCI: 4.452
Cites: 40
Cited by: 66
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security